[Interrelationship between impairment of reserve LH and TSH secretion capacity].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D002493:Central Nervous System Diseases / Q000503:physiopathology*; D003882:Dermatomyositis / Q000188:drug therapy; D005260:Female; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007018:Hypopituitarism / Q000503:physiopathology*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D007986:Luteinizing Hormone / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D013972:Thyrotropin / Q000378:metabolism*
D000305:Adrenal Cortex Hormones; D007986:Luteinizing Hormone; D013972:Thyrotropin